Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.59M Buy
40,463
+520
+1% +$61.8K 0.74% 33
2024
Q2
$4.95M Buy
39,943
+988
+3% +$127K 0.84% 31
2024
Q1
$5.14M Buy
38,955
+3,133
+9% +$386K 0.9% 31
2023
Q4
$3.91M Buy
35,822
+32,916
+1,133% +$3.42M 0.75% 34
2023
Q3
$299K Buy
2,906
+245
+9% +$26.4K 0.06% 70
2023
Q2
$307K Sell
2,661
-157
-6% -$17.8K 0.07% 64
2023
Q1
$300K Buy
2,818
+1
+0% +$108 0.07% 72
2022
Q4
$313K Buy
2,817
+1
+0% +$102 0.08% 58
2022
Q3
$243K Buy
2,816
+166
+6% +$14.8K 0.06% 68
2022
Q2
$242K Buy
2,650
+1
+0% +$89 0.1% 52
2022
Q1
$217K Buy
+2,649
New +$209K 0.06% 88

Other funds holding MRK

Gateway Advisory's MRK Position: Q3 2024 in Review

Gateway Advisory increased its Merck (MRK) stake by 1.3% in Q3 2024, buying an estimated $61.8K and bringing the position to 40,463 shares worth $4.59M. The position accounts for 0.74% of the portfolio, ranked #33.

Gateway Advisory first reported a position in MRK in Q1 2022 and has held it in 11 quarters since. The position peaked at $5.14M in Q1 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Gateway Advisory held 40,463 shares of Merck worth $4.59M as of Q3 2024.
  • Gateway Advisory bought 520 Merck shares in Q3 2024, an estimated $61.8K.
  • Merck made up 0.74% of Gateway Advisory's portfolio in Q3 2024, its #33 holding.
  • Gateway Advisory first reported a position in Merck in Q1 2022 and has held it in 11 quarters since.
  • Gateway Advisory's Merck position peaked at $5.14M in Q1 2024.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Gateway Advisory's 13F filing for Q3 2024, filed 14 Nov 2024.